At Piramal Pharma Solutions, we developed the ADCelerate™ program to provide comprehensive services for Antibody-Drug Conjugates (ADCs) and Bioconjugates, spanning from fragments, mAbs, payload-linkers, and conjugations to clinical and commercial manufacturing and fill/finish. Leveraging our robust network of world-class facilities, we streamline the pathway from R&D to GMP production, with guaranteed delivery at a fixed price.
Over the past two decades, we've honed our expertise and perfected our approach in this specialized segment, culminating in the successful development of hundreds of unique ADCs and the completion of more than 1,300 ADC batches. With our industry-leading, integrated ADC solutions, we empower our partners to accelerate their development timelines and bring innovative therapies to patients in the clinic faster.
FragmentsMonoclonal Antibodies
Payload-linkers
Bioconjugations
Sterile fill/finish 
